Anorexiants Market Report 2024 (Global Edition)

Global Anorexiants Market Report 2024 Market Size Split by Drug Class (Catecholamines, Serotonin), by Route of Administration (Oral, Subcutaneous), by Distribution Channel (Online Pharmacy, Retail Pha...

Anorexiants Market Report Description

We have various report editions of Anorexiants Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Anorexiants Market Insights Video

Competitive Landscape of the Anorexiants Market

The anorexiants market is competitive, with key players focusing on innovation and safety. Major pharmaceutical companies vie for market share by developing advanced formulations and addressing side effects. Regulatory scrutiny and the rise of alternative weight loss methods also shape the competitive dynamics, influencing market strategies and growth.

June 2023: Novo Nordisk expanded its obesity drug portfolio by launching a new high-dose formulation of an existing anorexiant in the U.S., enhancing its therapeutic offerings. (Source:https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=167030) February 2024: Arena Pharmaceuticals entered a strategic partnership with a digital health company to integrate personalized medicine approaches in anorexiant treatment plans. (Source:https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-arena-pharmaceuticalshttps://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2024/Teva-Announces-Launch-of-Authorized-Generic-of-Victoza-liraglutide-injection-1.8mg-in-the-United-States/default.aspx) March 2024: Teva Pharmaceuticals announced a joint venture with a healthcare provider to improve the distribution and accessibility of their anorexiant products across Europe. (Source:https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2024/Teva-and-Jiangsu-Nhwa-Forge-Strategic-Partnership-to-Promote-Patient-Access-to-AUSTEDO-in-China/default.aspxhttps://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2024/Teva-Announces-Launch-of-Authorized-Generic-of-Victoza-liraglutide-injection-1.8mg-in-the-United-States/default.aspx)

Top Companies Market Share in Anorexiants Industry: (In no particular order of Rank)

• Akrimax Pharmaceuticals LLC
• Janssen Ortho LLC
• Roche Pharmaceuticals
• Teva Pharmaceuticals
• Arena Pharmaceuticals GmbH
• Abbott Pharmaceuticals PR Ltd
• Epic Pharma LLC.
• Novo Nordisk A/S
• Patheon Pharmaceuticals Inc.
• Recordati Rare Diseases Inc.
• Catalent Pharma Solutions LLC
• MOVA Pharmaceuticals
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Anorexiants Market

Which Region Dominates the Anorexiants Market in 2024?

According to Cognitive Market Research, North America dominated the market in the year 2024. It accounted for around 40% of global revenue due to high obesity rates, advanced healthcare infrastructure, and significant investment in the research and development. Regulatory frameworks support new drug approvals, and a large consumer base with access to healthcare services drives demand for weight management solutions in the region.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Anorexiants market due to increasing obesity rates, rising health awareness, and expanding healthcare infrastructure. Economic growth in the region also drives greater access to weight management treatments while improving regulatory environments and increasing disposable incomes to further accelerate market expansion.

The current report Scope analyzes Anorexiants Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Anorexiants Market

According to Cognitive Market Research, the global Anorexiants market size was estimated at USD 951.2 Million, from which North America held the majority market of more than 40% of global revenue with the market size of USD 380.48 million in 2024 and will rise at the compound annual growth rate (CAGR) of 3.4% from the year 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Anorexiants market with a market size of USD 300.20 million in 2024 and is foreseen to rise at the CAGR of 3.2% during the forecast years due to the surging prevalence of obesity and associated health conditions.
• The Canada Anorexiants market had a market share of USD 45.66 million in the year 2024 and is foreseen to grow at the CAGR of 4.2% during the forecast years due to the increasing awareness of weight management among the population.
• The Mexico Anorexiants market is foreseen to experience growth at a CAGR of 3.9% during the forecast years, with the market size of USD 34.62 million in 2024.

Europe Anorexiants Market

According to Cognitive Market Research, the global Anorexiants market size was estimated at USD 951.2 Million, from which Europe held the market of more than 30% of global revenue with the market size of USD 385.2 million in the year 2024 and will rise at the compound annual growth rate (CAGR) of 3.7% from the year 2024 to 2031.

• The United Kingdom Anorexiants market had a market share of USD 47.94 million in 2024 and is foreseen to grow at a CAGR of 4.5% during the forecast period. In the UK, Anorexiants sales witness an upswing due to the increasing obesity rates and a growing focus on effective weight management solutions.
• The France Anorexiants market is foreseen to experience growth at the CAGR of 2.9% during the forecast years, with a market size of USD 26.25 million in 2024.
• According to Cognitive Market Research, the German Anorexiants market size was valued at USD 56.50 million in 2024 and is foreseen to rise at a CAGR of 3.9% during the forecast years due to the surging prevalence of obesity and associated health conditions.
• The Italy Anorexiants market is foreseen to experience growth at a CAGR of 3.1% during the forecast years, with a market size of USD 24.54 million in 2024.
• The Russia Anorexiants market is foreseen to experience growth at a CAGR of 2.7% during the forecast years, with a market size of USD 44.23 million in 2024.
• The Spain Anorexiants market is foreseen to experience growth at a CAGR of 2.8% during the forecast years with a market size of USD 23.40 million in 2024
• The Luxembourg Anorexiants market is foreseen to experience growth at a CAGR of 3.8% during the forecast years, with a market size of USD 8.85 million in 2024.
• The Portugal Anorexiants market is foreseen to experience growth at a CAGR of 3.5% during the forecast years, with a market size of USD 5.99 million in 2024.
• The Greece Anorexiants market is foreseen to experience growth at a CAGR of 4.0% during the forecast years, with a market size of USD 3.42 million in 2024.
• Rest of Europe's Anorexiants market is foreseen to experience growth at a CAGR of 2.4% during the forecast years, with a market size of USD 44.23 million in 2024.

Asia Pacific Anorexiants Market

According to Cognitive Market Research, the global Anorexiants market size was estimated at USD 951.2 Million, from which Asia Pacific held the market of around 23% of global revenue with the market size of USD 347.2 million in the year 2024 and will rise at the compound annual growth rate (CAGR) of 7.2% from the year 2024 to 2031.

• According to Cognitive Market Research, the China Anorexiants market size was valued at USD 98.45 million in 2024 and is foreseen to rise at the CAGR of 6.7% during the forecast years due to the increasing prevalence of obesity and rising health consciousness among the population.
• The Japan Anorexiants market is foreseen to experience growth at a CAGR of 5.7% during the forecast years, with a market size of USD 30.19 million in 2024.
• The India Anorexiants market had a market share of USD 26.25 million in the year 2024 and is foreseen to grow at the CAGR of 9.0% during the forecast years due to the increasing prevalence of obesity and lifestyle-related health issues.
• The South Korean Anorexiants market is foreseen to experience growth at a CAGR of 6.3% during the forecast years, with a market size of USD 21.88 million in 2024.
• The Australian Anorexiants market is foreseen to experience growth at a CAGR of 6.9% during the forecast years, with a market size of USD 11.38 million in 2024.
• The South East Asia Anorexiants market is foreseen to experience growth at a CAGR of 8.2% during the forecast years, with a market size of USD 15.10 million in 2024.
• The Rest of the Asia Pacific Anorexiants market is foreseen to experience growth at a CAGR of 7.0% during the forecast years, with a market size of USD 15.53 million in 2024.

South America Anorexiants Market

According to Cognitive Market Research, the global Anorexiants market size was estimated at USD 951.2 Million, from which the Latin America market has more than 5% of global revenue with the market size of USD 71.9 million in the year the year 2024 and will rise at the compound annual growth rate (CAGR) of 4.6% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Anorexiants market size was valued at USD 20.36 million in the year 2024 and is foreseen to rise at the CAGR of 5.2% during the forecast years. Anorexiants flourished in Brazil due to the rising prevalence of obesity and increasing consumer awareness about weight management and health.
• Argentina's Anorexiants market had a market share of USD 7.99 million in the year 2024 and is foreseen to rise at a CAGR of 5.5% during the forecast years due to the rising demand for the effective weight management solutions.
• Colombia Anorexiants market is foreseen to experince growth at the CAGR of 4.4% during the forecast years, with a market size of USD 4.23 million in 2024.
• Peru Anorexiants market is foreseen to experience growth at the CAGR of 4.8% during the forecast years, with the market size of USD 3.90 million in 2024.
• Chile Anorexiants market is foreseen to experience growth at the CAGR of 4.9% during the forecast years, with the market size of USD 3.42 million in 2024.
• The Rest of Latin America's Anorexiants market is foreseen to experience growth at the CAGR of 3.7% during the forecast years, with the market size of USD 7.66 million in 2024.

Middle East and Africa Anorexiants Market

According to Cognitive Market Research, the global Anorexiants market size was estimated at USD 951.2 Million, from which the Middle East and Africa held the majority market of around 2% of the global revenue with the market size of USD 28.5 million in the year 2024 and will rise at the compound annual growth rate (CAGR) of 4.9% from 2024 to 2031..

• The GCC Countries Anorexiants market is foreseen to experience growth at a CAGR of 5.7% during the forecast years, with a market size of USD 8.14 million in 2024. Anorexiants sales flourish due to the increasing awareness of weight management and wellness.
• The Egypt Anorexiants market is foreseen to experience growth at the CAGR of 5.2% during the forecast years, with the market size of USD 2.00 million in 2024.
• The South Africa Anorexiants market is foreseen to experience growth at the CAGR of 5.9% during the forecast years, with a market size of USD 3.01 million in 2024. Anorexiant sales flourish in South Africa due to technological advancements, increasing demand, and regulatory support.
• The Turkey Anorexiants market is foreseen to experience growth at a CAGR of 4.4% during the forecast years, with a market size of USD 1.64 million in 2024.
• The Nigeria Anorexiants market is foreseen to experience growth at a CAGR of 4.0% during the forecast years, with a market size of USD 2.00 million in 2024.
• The Rest of the MEA Anorexiants market is foreseen to experience growth at a CAGR of 3.9% during the forecast years, with a market size of USD 2.24 million in 2024.

Anorexiants Market Analysis

How are Segments Performing in the Global Anorexiants Market?

Anorexiants Market Drug Class Segment Analysis

According to Cognitive Market Research, catecholamines stand out as the dominant category over the projected period due to their effectiveness in suppressing appetite by increasing neurotransmitter levels like norepinephrine and dopamine. Their well-established efficacy in weight management and long-standing clinical use contribute to their leading position despite concerns over potential side effects and regulatory scrutiny.

Serotonin is the fastest-growing category in the Anorexiants market due to its effectiveness in appetite suppression and mood regulation, which enhances compliance and results. Their ability to target specific neurotransmitter systems minimizes side effects compared to other options, making them increasingly popular in the market for weight management and obesity treatment.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Anorexiants Industry. Request a Free Sample PDF!

Anorexiants Market Route of Administration Segment Analysis

According to Cognitive Market Research, the dominant category is oral administration due to its ease of use, convenience, and patient compliance. Oral tablets and capsules offer a non-invasive, straightforward method for delivering medication, which enhances adherence and allows for consistent, controlled dosage, making it the preferred route for both patients and healthcare providers.

The fastest-growing category in the Anorexiants market is subcutaneous administration due to its ease of use, minimal invasiveness, and enhanced patient compliance. This delivery method allows for convenient self-administration, which improves treatment adherence and effectiveness. Additionally, it offers more stable drug absorption compared to oral or intravenous methods, driving its increasing popularity.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Anorexiants Distribution Channel Segment Analysis

Anorexiants Market Distribution Channel Segment Analysis

According to Cognitive Market Research, the dominant category is online pharmacy, by offers convenient access, discreet purchasing options, and often lower prices compared to brick-and-mortar stores. They capitalize on the growing trend of e-commerce and telemedicine, making it easier for consumers to obtain anorexiants while navigating regulatory and privacy concerns.

The fastest-growing category in the Anorexiants market is retail pharmacy due to increased consumer preference for convenient access to medications. Enhanced patient awareness, the availability of over-the-counter anorexiants, and growing retail pharmacy chains drive this growth. Retail settings offer easy access and personalized services, making them a preferred choice for weight management solutions.

• Online Pharmacy
• Retail Pharmacy
• Hospital Pharmacy

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion